Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

1.6K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.6K
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

1.7K
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.7K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

1.2K
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.2K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

1.0K
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
1.0K
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

65
Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
65
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

71
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant...
71

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Online Group Hypnotherapy for Irritable Bowel Syndrome-a Pilot Study.

Neurogastroenterology and motility·2026
Same author

Design of Treatment Trials for Disorders of Gut-Brain Interaction.

Gastroenterology·2026
Same author

Primary carE PPi dEprescRibing (PEPPER) trial: a protocol for determining the optimal strategy for stopping chronic proton pump inhibitor therapy in primary care patients.

BMJ open·2026
Same author

Effect of a histamine-rich meal versus a low-histamine-containing meal on urinary histamine and N-methylhistamine excretion.

Journal of gastroenterology·2026
Same author

Symptom Patterns Outside the Rome IV Consensus in Eastern and Western Patients With a Disorder of Gut-Brain Interaction.

The American journal of gastroenterology·2026
Same author

Bloating, Visible Abdominal Distension, and Other Intestinal Gas-Related Symptoms in Irritable Bowel Syndrome and Functional Dyspepsia.

United European gastroenterology journal·2026
Same journal

How important is fiber in the Crohn's disease story?

Gastroenterology·2026
Same journal

Reply to "Critical Appraisal of the Integrin αV-YAP-CTGF Axis in Congestive Hepatopathy".

Gastroenterology·2026
Same journal

Critical Appraisal of the Integrin αV-YAP-CTGF Axis in Congestive Hepatopathy.

Gastroenterology·2026
Same journal

A High-Risk Impaction: To Scope or to Stent First?

Gastroenterology·2026
Same journal

Epithelial FOXP3 orchestrates O-glycosylated IL-6 secretion to drive pancreatic fibrocarcinogenesis.

Gastroenterology·2026
Same journal

Reply to "Methodological Considerations on Neonatal Metabolomics and Future Inflammatory Bowel Disease".

Gastroenterology·2026
関連記事をすべて見る

関連する実験動画

Updated: May 5, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

6.3K

ガストロドウデナルの疾患

Hans Törnblom1, Florencia Carbone2, William L Hasler3

  • 1Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden; Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.

Gastroenterology
|February 19, 2026
PubMed
まとめ
この要約は機械生成です。

この研究では,胃腸腸症候群を5つのカテゴリーに分類し,機能性消化不良,吐き気および嘔吐障害,過剰な漏障害,漏不全症候群,および反症候群を含む. これらの分類は,上部胃腸疾患を理解し,診断するのに役立ちます.

キーワード:
ベルチング (Belching) とは,ベルチング (Belching) とは,ベルチング (Belching) とはディスペプシア症候群 (Dyspepsia) とは吐き気 吐き気ルーミネーション ルーミネーション

さらに関連する動画

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
03:48

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research

Published on: March 1, 2024

1.9K
Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
05:30

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

464

関連する実験動画

Last Updated: May 5, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

6.3K
Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
03:48

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research

Published on: March 1, 2024

1.9K
Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
05:30

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

464

科学分野:

  • 胃腸内科 胃腸内科
  • 消化器官の健康について
  • 臨床症状学 臨床症状学

背景:

  • ガストロドウデナルの症状は一般的であり,しばしば診断上の課題を提示します.
  • 既存の分類は,上部胃腸疾患のスペクトルを完全にカバーしていない可能性があります.
  • 正確な診断と管理のために,標準化された分類システムが必要である.

研究 の 目的:

  • ガストロドゥオデナール領域に起因する症状の包括的な分類システムを提案する.
  • ガストロドゥオデナル疾患の異なるカテゴリーとサブカテゴリーを区分する.
  • 臨床評価と研究のための枠組みを提供すること.

主な方法:

  • ガストロドゥオデナル症状に関する既存の文献のレビューと合成.
  • 症状の表現と特徴に基づく階層的分類の開発.
  • 既定および新規の症状カテゴリーの含有.

主要な成果:

  • ガストロデュオデナル症状の5つの主要なカテゴリが特定されました:機能性消化不良,吐き気および嘔吐障害,過剰な漏障害,漏不全症候群,および反症候群.
  • 機能性消化不良症はさらに食後ストレス症候群と上胃痛症候群に分けられた.
  • 吐き気および嘔吐障害は,慢性吐き気および嘔吐症候群,周期性嘔吐症候群,およびカンナビノイドハイペレメシス症候群を含む.

結論:

  • 提案された分類は,胃腸胃腸の症状を理解するための構造的なアプローチを提供します.
  • この枠組みは,診断の正確性を向上させ,治療戦略を導くことができます.
  • この分類のさらなる検証と臨床適用は正当である.